Skip to main content
. 2024 Dec 17;19:13461–13483. doi: 10.2147/IJN.S498729

Table 1.

Nanoparticles in Bladder Cancer Therapy

Therapies Nanocarriers Payloads Anti-tumor Strategy References
Chemotherapy Nanodiamond VitaminA analogs Enhanced the penetration into tumor [7,8]
Doxorubicin Enhanced cytotoxicity
Polymeric nanostructure Pirabucin Efficient delivery [9]
Nanoliposome Vincristine Reduced side effects [10,11]
Poly(L-aspartic acid sodium salt) nanoparticle Cisplatin Reduced side effects [12]
Glutathione-responsive nanoparticle Cisplatin prodrug (Pt(IV)) Overcome drug resistance [13]
Gene Therapy Mesoporous silica nanoparticles siRNA Enhanced targeting ability [14]
Lipid nanoparticle [15]
Chrysotile nanotubes circRNA Enhanced passive targeting ability [16]
Exosome Enhanced active targeting ability [17,18]
Immunotherapy MNC-ICG-NIG@SiO2 nanoparticles BCG Precisely controlled of drug release in tumor [19]
Macrophage-derived exosome-mimetic nanovesicles PD-L1 inhibitor Blocking immunosuppression [20]
Poly (propylglycolide-co-glycolide) nanoparticles Toll-like receptor 7/8 agonist Enhanced immune response [21]
Phototherapy HSA-Ce6/NTZ/FCS nanoparticles Chlorin e6 Enhanced transmucosal delivery [22]
Tumor-specific ligands Chlorin e6 Enhanced targeting ability [23]
Mesoporous silica nanoparticles - Enhanced phototoxicity [24]
Gold nanorods MnO2 Enhanced drug release in tumor microenvironment [25]